返回首页

VASH1 Q7L8A9

微管蛋白酪氨酸羧肽酶1 (EC 3.4.17.17) (微管蛋白羧肽酶1) (酪氨酸羧肽酶1) (TTCP 1) (Vasohibin-1)

蛋白质信息 (UniProt)

微管蛋白酪氨酸羧肽酶1 (EC 3.4.17.17) (微管蛋白羧肽酶1) (酪氨酸羧肽酶1) (TTCP 1) (Vasohibin-1)

Q7L8A9

功能描述

酪氨酸羧肽酶,可去除alpha-tubulin的C末端酪氨酸残基,从而调节微管动力学和功能 (PubMed:29146869, PubMed:31171830, PubMed:31235910, PubMed:31235911, PubMed:31270470)。对于有丝分裂期间的纺锤体功能和准确的染色体分离至关重要,因为微管去酪氨酸化调节有丝分裂纺锤体的长度和定位 (PubMed:31171830)。作为血管生成抑制剂:抑制内皮细胞的迁移、增殖和网络形成以及血管生成 (PubMed:15467828, PubMed:16488400, PubMed:16707096, PubMed:19204325)。这种抑制作用对内皮细胞具有选择性,因为它不影响平滑肌细胞或成纤维细胞的迁移 (PubMed:15467828, PubMed:16488400, PubMed:16707096)。 {ECO:0000269|PubMed:15467828, ECO:0000269|PubMed:16488400, ECO:0000269|PubMed:16707096, ECO:0000269|PubMed:19204325, ECO:0000269|PubMed:29146869, ECO:0000269|PubMed:31171830, ECO:0000269|PubMed:31235910, ECO:0000269|PubMed:31235911, ECO:0000269|PubMed:31270470}。

组织特异性

Preferentially expressed in endothelial cells (PubMed:15467828, PubMed:16707096). Highly expressed in fetal organs (PubMed:15467828). Expressed in brain and placenta, and at lower level in heart and kidney (PubMed:15467828). Highly detected in microvessels endothelial cells of atherosclerotic lesions (PubMed:16707096).

亚细胞定位

Cytoplasm

关键词

3D-structure Alternative splicing Carboxypeptidase Cell cycle Cytoplasm Growth arrest Hydrolase Protease Proteomics identification Reference proteome